Skip to main content
. 2018 Apr 2;24(6):327–340. doi: 10.1093/molehr/gay013

Figure 1.

Figure 1

Effect of in vivo treatments with the mTOR inhibitor rapamycin during Days 7–9 of pregnancy on decidual protein levels of (a) FABP4, (b) PLIN2, (c) PPARγ and (d) PPARδ, evaluated on Day 9 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical analysis: Student t test. *P < 0.05, **P < 0.01 and ***P < 0.001 versus control. Representative photos of FABP4 and PLIN2 in the decidua, yolk sac and uterine glands are shown. D, decidua. E, embryo. White arrows point to the yolk sac. Black arrows point to immunostained uterine gland cells.